title: Cardiac structure and function in fetuses of mothers infected with HIV: the prospective PCHIV multicenter study.
abstract: BACKGROUND
  This study was designed to determine if vertically transmitted HIV infection and maternal infection with HIV are associated with altered cardiovascular structure and function in utero.
  
  
  METHODS
  Fetal echocardiography was performed in 173 fetuses of 169 HIV-infected mothers (mean gestational age, 33.0 weeks; SD = 3.7 weeks) at 5 centers. Biparietal diameter, femur length, cardiovascular dimensions, and Doppler velocities through atrioventricular and semilunar valves and the umbilical artery were measured. Measurements were converted to z scores based on published normal data.
  
  
  RESULTS
  Fetuses determined after birth to be HIV-infected had similar echocardiographic findings as fetuses later determined to be HIV-uninfected except for slightly smaller left ventricular diastolic dimensions (P =.01). The femur length (P =.03) was also smaller in the fetuses postnatally identified as HIV-infected. Differences in cardiovascular dimensions and Doppler velocities were identified between fetuses of HIV-infected women and previously published normal fetal data. The reason for the differences may be a result of maternal HIV infection, maternal risk factors, or selection bias in the external control data.
  
  
  CONCLUSIONS
  Vertically transmitted HIV infection may be associated with reduced left ventricular size but not with altered cardiac function in utero. Fetuses of HIV-infected mothers may have abnormal cardiovascular structure and function and increased placental vascular resistance, regardless of whether the fetuses are subsequently found to be infected with HIV.
authors.affiliation: Department of Cardiology, Children's Hospital, Department of Pediatrics, Harvard Medical School, Boston, MA, USA. hornberg@sickkids.on.ca
authors.forename: L K
authors.initials: LK
authors.lastname: Hornberger
authors.forename: S E
authors.initials: SE
authors.lastname: Lipshultz
authors.forename: K A
authors.initials: KA
authors.lastname: Easley
authors.forename: S D
authors.initials: SD
authors.lastname: Colan
authors.forename: M
authors.initials: M
authors.lastname: Schwartz
authors.forename: S
authors.initials: S
authors.lastname: Kaplan
authors.forename: T J
authors.initials: TJ
authors.lastname: Starc
authors.forename: N A
authors.initials: NA
authors.lastname: Ayres
authors.forename: W W
authors.initials: WW
authors.lastname: Lai
authors.forename: D S
authors.initials: DS
authors.lastname: Moodie
authors.forename: C
authors.initials: C
authors.lastname: Kasten-Sportes
authors.forename: S P
authors.initials: SP
authors.lastname: Sanders
mesh_terms: D000328:Adult; D001783:Blood Flow Velocity / Q000502:physiology; D015150:Echocardiography, Doppler; D005260:Female; D005318:Fetal Heart / Q000000981:diagnostic imaging* / Q000503:physiopathology; D005865:Gestational Age; D006678:HIV / Q000276:immunology; D015483:HIV Antibodies / Q000032:analysis; D015658:HIV Infections / Q000000981:diagnostic imaging* / Q000635:transmission / Q000821:virology; D006330:Heart Defects, Congenital / Q000000981:diagnostic imaging / Q000209:etiology / Q000503:physiopathology; D006352:Heart Ventricles / Q000000981:diagnostic imaging / Q000503:physiopathology; D006801:Humans; D018445:Infectious Disease Transmission, Vertical; D018811:Maternal Exposure; D009200:Myocardial Contraction / Q000502:physiology; D011247:Pregnancy; D011256:Pregnancy Outcome; D011379:Prognosis; D011446:Prospective Studies; D016216:Ultrasonography, Prenatal / Q000379:methods*
chemical_list: D015483:HIV Antibodies